Cellid
PrivateLast Round
Series C
Extension
Apr 15, 2025
Total Funding Raised
$41.87M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellid is an augmented reality technology company that develops display modules and spatial recognition software for AR glasses, including waveguides and recognition engines, to help customers interpret data on human movement and environmental interactions.
Sector
Frontier & Industrial Tech
Verticals
AR/VR Hardware, Computer Vision, AR/VR Experiences
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellid Comparables
Compare Cellid with similar companies based on industry and business-model similarity.
Cellid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Apr 15, 2025 | ||||
| Early Funding | Feb 6, 2025 | ||||
| Strategic | Jan 30, 2024 | ||||
| Series A | Nov 17, 2023 | ||||
| Early Funding | Jun 23, 2023 | ||||
Series B | Dec 16, 2022 |
Key People
Founding team and executive leadership
Cellid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Development Bank of Japan | Early Funding |
| SMBC Nikko Securities | Series A |
| Global Brain Corporation | Early Funding |
| 株式会社FFGベンチャービジネスパートナーズ | Early Funding |
| More Management Co., Ltd. | Early Funding |
| TEL Venture Capital | Early Funding |
| 15th Rock | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 110% MoM, reaching 11.6K.
- Apr 7, 2026
Opened a new office in Taoyuan, Taiwan.
Recent news
Latest coverage and updates
- attends_eventOct 12, 2026
Cellid, Inc. is set to attend Augmented Enterprise Summit 2026 and run live demonstrations of Crux in a dedicated meeting room at the venue in Georgia in Oct '26.
- attends_eventOct 1, 2026
Cellid, Inc.'s AR glasses reference design and disassembled HJ1 AI Smart Glasses components are on display at the "Extended Reality: Visions of the Future" Exhibition in California from Oct 1st '26 through Mar 28th '27.
- is_developingOct 1, 2026
Cellid, Inc. develops AR glasses reference designs that demonstrate how its waveguide and display technologies support lightweight, practical AR eyewear.
- launchesSep 25, 2026
Cellid, Inc. launches Crux at Snapdragon Summit 2026.
- partners_withSep 25, 2026
On Sep 25th '26 in Japan, Cellid, Inc. and Megane Top Co., Ltd. partner to develop, commercialize, and expand AR glasses under Megane Top Co., Ltd.'s own brand, with preorders starting Oct 23rd '26.
Cellid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellid's valuation, stock price, and market status.
Is Cellid a public or private company?
Cellid is a private company.
What is the current stock price of Cellid?
Cellid is a private company, so its shares have no public market price. Caplight tracks Cellid's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellid worth (valuation)?
Valuation information for Cellid is not publicly available.
Can I buy Cellid stock?
Cellid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellid's last funding round?
Cellid's most recent funding round was Series C Extension on April 15, 2025.
Who are the main investors in Cellid?
Key investors in Cellid include Development Bank of Japan.
Will Cellid IPO soon?
No public IPO plans have been announced for Cellid.
How can I track Cellid secondary market activity?
Caplight tracks bids, offers, and trades in Cellid's shares on secondary markets.